NCT03429283

Brief Summary

Data extraction from bacteriological laboratory of Martinique University hospital to determine the frequency and the distribution of nosocomial infections due to Achromobacter xylosoxidans (ACHX), an emerging multi-resistant environmental bacteria. The specific tropical environment and climatic conditions in Martinique may favor ACHX development and the investigators suppose that this new opportunistic pathogen can represent a danger for hospitalized patients. The aim of our study is to describe the most affected population and try to identify the main environmental sources of contamination.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2016

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2016

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

December 7, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 12, 2018

Completed
Last Updated

July 24, 2019

Status Verified

February 1, 2018

Enrollment Period

7 months

First QC Date

December 7, 2017

Last Update Submit

July 22, 2019

Conditions

Nosocomial Infection

Keywords

Epidemiology,Achromobacter xylosoxidans,antibiotic resistance

Outcome Measures

Primary Outcomes (1)

  • The incidence rate of Achromobacter xylosoxidans nosocomial infections

    number of infections/ total number of patients hospitalized in our institution

    january 2006 to december 2016

Secondary Outcomes (2)

  • The incidence density of Achromobacter xylosoxidans nosocomial infections

    january 2006 to december 2016

  • Mortality rate related to ACHX,

    january 2006 to december 2016

Interventions

descriptive retrospective epidemiological studyOTHER

descriptive retrospective epidemiological study

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients hospitalized

You may qualify if:

  • Patients hospitalized in Martinique University Hospital, Pierre Zobda Quitman site, from January 2006 to December 2016, with biological sample positive to ACHX

You may not qualify if:

  • Patient hospitalized in another site…
  • Patients hospitalized less than 48h before bacteriological analysis……

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Martinique

Fort-de-France, 97261, Martinique

Location

MeSH Terms

Conditions

Cross Infection

Condition Hierarchy (Ancestors)

InfectionsIatrogenic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Karine SANCHEZ, Pharma D

    Martinique University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 7, 2017

First Posted

February 12, 2018

Study Start

October 1, 2016

Primary Completion

May 1, 2017

Study Completion

June 1, 2017

Last Updated

July 24, 2019

Record last verified: 2018-02

Data Sharing

IPD Sharing
Will not share

Locations

MA(1)